Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results | Radiation Oncology | Full Text

Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results | Radiation Oncology | Full Text

Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results

The use of stereotactic body radiotherapy (SBRT) as the primary treatment modality in clinically localized prostate cancer (PCa) is emerging. The aim of the study was to analyze the long-term results of PCa pa...

Authors:Kristiina Vuolukka, Päivi Auvinen, Erno Tiainen, Jan-Erik Palmgren, Janne Heikkilä, Jan Seppälä, Sirpa Aaltomaa and Vesa Kataja

Citation:Radiation Oncology 2020 15:173

Content type:Research

 

Published on: 14 July 2020

• ViewFull Text
 
• ViewPDF